Skip to main content
. 2022 Jun 7;13(6):533. doi: 10.1038/s41419-022-04979-3

Fig. 7. Schematic depiction and molecular mechanisms of early rapid clinical progression of patients with BPH.

Fig. 7

The CYP19/estrogen/GPER/Gαi pathway triggers the early rapid clinical progression of patients with BPH by promoting prostatic fibrosis and prostatic stromal cell proliferation.